Results
|
|
1.
|
|
|
|
2.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
|
3.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
